We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Threat for Missing Study May Be Wider Warning to Industry
Merck Threat for Missing Study May Be Wider Warning to Industry
March 2, 2012
The FDA has warned Merck that it could face fines for being months late on two postmarket study deadlines to assess acute pancreatitis risk with diabetes drugs Janumet and Januvia.